Voyager Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Voyager Therapeutics

08/11/2022 14:32

* Voyager Therapeutics Inc  VYGR.OQ  reported quarterly
adjusted
earnings of 45 cents​​ per share for the quarter ended in
September. The mean expectation of seven analysts for the
quarter was for a loss of 32 cents per share.
    * Revenue rose 2,672.3% to $41.09 million from a year ago;
analysts expected $9.42 million. 
    * Voyager Therapeutics Inc's reported EPS for the quarter
was 45
cents​.
    * The mean earnings estimate of analysts had risen by
about 27.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Voyager Therapeutics Inc shares had fallen by 19.1% this
quarter and gained 76.8% so far this year.
    * The company reported quarterly net income of $17.62
million.
    * Wall Street's median 12-month price target for Voyager
Therapeutics Inc is $7.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
8 at 02:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.32          0.45           Beat
 Jun. 30 2022      -0.32          -0.50          Missed
 Mar. 31 2022      -0.34          -0.56          Missed
 Dec. 31 2021      -0.32          0.15           Beat